Boston Scientific device wins approval in Europe
Boston Scientific Corp., the second-biggest maker of heart devices, received marketing approval in Europe for its implantable Livian, used to monitor heartbeats and deliver electrical jolts to improve pumping ability. The Livian device, not available for sale in the United States, is under review by the Food and Drug Administration, Natick-based Boston Scientific said. The device is used to treat patients with heart failure. The approval is the first for Boston Scientific of one of its cardiac rhythm devices for heart failure
No comments:
Post a Comment